NQO1 and hearing loss disorder: The reaction of NQO1 with β-lapachone exerts beneficial effects on symptoms of aging, obesity, hypertension, arterial restenosis, acute pancreatitis, cisplatin-mediated acute kidney injury, and hearing impairment (32–34).